3,5-disubstituted-(1,2,4)-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

Details for Australian Patent Application No. 2003303373 (hide)

Owner Cytovia, Inc.

Inventors Kuemmerle, Jared D.; Zhang, Hong; Zhang, Han-Zhong; Kemnitzer, William E.; Cai, Sui Xiong

Agent Houlihan2

Pub. Number AU-B-2003303373

PCT Number PCT/US2003/0403

PCT Pub. Number WO2004/058253

Priority 60/433,953 18.12.02 US

Filing date 18 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 11 February 2010

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/4439 (2006.01)

Event Publications

19 August 2004 Complete Application Filed

  Priority application(s): 60/433,953 18.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-B-2003303373

11 February 2010 Application Accepted

  Published as AU-B-2003303373

10 June 2010 Standard Patent Sealed

10 June 2010 Corrigenda

  Applications Accepted - Name Index Under the name Cytovia, Inc., Application No. 2003303373, under INID (54) correct the title to read 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003303374-TREATMENT OF METASTATIC CANCER WITH THE B-SUBUNIT OF SHIGA TOXIN

2003303372-SYSTEM, METHOD AND APPLIANCES FOR APPLYING HAIR TREATMENTS